Physician profile
John Robert Miller
NPI 1528367836
$10,125.98
in general payments reported to CMS, 2019-2025
9 companies · $2,503 in 2025
The $2,503 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,355 · 2020: $432 · 2021: $2,668 · 2022: $1,679 · 2023: $1,195 · 2024: $294 · 2025: $2,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,322 · Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,322.33 |
| Food and Beverage | $1,669.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $4,854.90 | 2019-2023 | |
| Arthrex, INC. | $2,198.09 | 2019-2025 | Knee & Hip Implants Meniscal Repair Fiberstitch |
| Oak Med, INC. | $1,280.37 | 2024-2025 | |
| Stryker Corporation | $735.73 | 2019-2025 | Inspace, Alphavent, Omega |
| Depuy Synthes Sales INC. | $627.31 | 2019-2025 | Na |
| Smith+Nephew, INC. | $143.96 | 2025 | |
| Vericel Corporation | $142.49 | 2023 | Maci |
| Janssen Pharmaceuticals, INC | $122.12 | 2019 | |
| Abbott Laboratories | $21.01 | 2023 | Amplatzer Talisman |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.